Pneumococcal Vaccine and Patients with Chronic Lung Disease
Annals of Internal MedicinePublished 1 January 1986
James H. Williams, KENNETH M. MOSER
Citations54
SJR quartileQ1
SJR score3.38
SNIP3.27
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Routine vaccination of all patients with chronic lung disease is not warranted, on the basis of available data, and data suggest that the protection provided by the vaccine in healthy persons may be reduced in patients with Chronic lung disease.
Abstract
We reviewed data that evaluated both the risk for pneumococcal pneumonia in patients with chronic lung disease and the protection afforded these patients by current pneumococcal vaccines. No conclusive documentation of increased risk for pneumococcal pneumonia in this population exists, and data suggest that the protection provided by the vaccine in healthy persons may be reduced in patients with chronic lung disease. We conclude, on the basis of available data, that routine vaccination of all patients with chronic lung disease is not warranted.
Keywords
MedicineHealth Professions
New England Journal of MedicineThe Importance of Beta, the Type II Error and Sample Size in the Design and Interpretation of the Randomized Control Trial
1,641 Citations1978Jennie A. Freiman, Thomas C. Chalmers +2 more
Annals of Internal MedicinePneumococcal Bacteremia with Especial Reference to Bacteremic Pneumococcal Pneumonia
935 Citations1964Robert Austrian, JEROME GOLD
Twenty-five years have elapsed since the subject of pneumococcal bacteremia has been reviewed, and in that period many changes have taken place both in the treatment of this disorder and in the research into its causes.
The Journal of Infectious DiseasesConsiderations for Formulating the Second-Generation Pneumococcal Capsular Polysaccharide Vaccine with Emphasis on the Cross-Reactive Types Within Groups
565 Citations1983John B. Robbins, Robert Austrian +9 more
New England Journal of MedicinePneumococcal Disease after Pneumococcal Vaccination
344 Citations1980Claire V. Broome, Richard R. Facklam +1 more
Trials of pneumococcal vaccine in healthy young adult populations suggest 75 to 95 per cent type-specific efficacy, but trials have not been done, however, in groups for which pneumococCal vac...
Clinical Infectious DiseasesSome Observations on the Pneumococcus and on the Current Status of Pneumococcal Disease and Its Prevention
291 Citations1981Robert Austrian
Refinements in understanding the pathogenesis of pneumococcal pneumonia, bacteremia, and otitis media are reviewed, and current knowledge of the epidemiology of pneumitiscal infections and of the distribution ofneumococcal types causing such infections is discussed.
Annals of Internal MedicineA Controlled Evaluation of the Protective Efficacy of Pneumococcal Vaccine for Patients at High Risk of Serious Pneumococcal Infections
262 Citations1984Eugene D. Shapiro, JOHN D. CLEMENS
Pneumococcal vaccine confers substantial protection against systemic pneumococcal infections on the elderly and patients with illnesses associated with a moderately increased risk of pneumitiscal infections.
JAMAFailure of Intensive Care Unit Support to Influence Mortality From Pneumococcal Bacteremia
258 Citations1983Edward W. Hook
BMJPneumococcal bacteraemia: 325 episodes diagnosed at St Thomas's Hospital.
197 Citations1985W. R. Gransden, Susannah Eykyn +1 more
Three hundred and twenty five episodes of pneumococcal bacteraemia occurred at St Thomas's Hospital during 1970-84, accounting for 13.3% of all episodes of bacteraemic cases, and common predisposing factors included chronic chest disease, alcoholism, haematological malignancies, cirrhosis, and sickle cell anaemia.
The LancetIMMUNISATION WITH A POLYVALENT PNEUMOCOCCAL VACCINE
183 Citations1977Ian Riley, Matthew Andrews +6 more
A double-blind controlled trial of a 14-valent pneumococcal polysaccharide vaccine was carried out in 11 958 adults at Tari in the Papua New Guinea Highlands and death from pneumonia was less in the vaccinated group.
Archives of Internal MedicineCLINICAL SIGNIFICANCE OF BACTEREMIA IN PNEUMOCOCCIC PNEUMONIA
165 Citations1937R. Carmichael Tilghman
The purpose of this study is to correlate the incidence of bacteremia and the death rate with the more common factors known or supposed to influence the prognosis, including the type of pneumococcus, age of the patient, sex and the sex.
PubMedBacteriologic diagnosis of acute pneumonia. Comparison of sputum, transtracheal aspirates, and lung aspirates.
151 Citations1976Michael Davidson, Bruce Tempest +1 more
Journal of the American Geriatrics SocietyPneumococcal Bacteremia in Adults
148 Citations1983Martin S. Finkelstein, William Petkun +2 more
Older patients (aged 65 or older) more frequently had a lower fever in response to the infection, an unclear history of illness, a delay in diagnosis and/or therapy, and a higher risk of dying.
Clinical Infectious DiseasesPneumococcus: The First One Hundred Years
146 Citations1981Robert Austrian
Because of the vast store of knowledge of the pneumococcus that has been acquired in the past 100 years, the hope is expressed that this knowledge will continue to grow and to serve as a basis for the extension of understanding both the bacterial cells and of the processes of infection.
Annals of Internal MedicinePneumococcal Vaccine: Clinical Efficacy and Effectiveness
135 Citations1982J. Sanford Schwartz
Findings of a literature review suggest vaccinating high-risk patients immunologically competent to produce homotypic antibodies in response to vaccination with polysaccharide antigen, while continuing investigation of disease incidence, severity, serotype distribution, and immunologic response among high- risk groups and postmarketing surveillance efforts among all vaccinated patients.
American Journal of EpidemiologyPNEUMOCOCCAL BACTEREMIA IN CHARLESTON COUNTY, SOUTH CAROLINA1
130 Citations1980Gregory Filice, Charles P. Darby +1 more
The data suggest that certain groups would benefit from vaccination against pneumococcal disease if the vaccines are shown to be safe and effective for these groups.
PubMedDetection of type-specific pneumococcal antigens by counterimmunoelectrophoresis. I. Methodology and immunologic properties of pneumococcal antigens.
127 Citations1973Coonrod Jd, Rytel Mw
Pneumococcal capsular antigen in serum and pleural fluid from a case of pneumonia had the same reactivity in the CIE test as PPP and gave reactions of complete identity with PPP in double-diffusion tests.
JAMAPneumococcal Disease in a Medium-Sized Community in the United States
125 Citations1982Maurice A. Mufson
All hospitalized patients who had Streptococcus pneumoniae isolated from blood, CSF, pleural fluid, or ascitic fluid during the years 1978 through 1981 in Huntington, WVa, and environs provide a basis for widespread use of pneumococcal vaccine in high-risk groups.
PubMedDiagnostic accuracy of transtracheal aspiration bacteriologic studies.
123 Citations1977John G. Bartlett
Clinical correlations in 119 patients with negative cultures of transtracheal aspirate indicated that 71 had an alternative diagnosis to explain an abnormal chest radiograph, and 44 appeared to have a bacterial infection but had received antimicrobial drugs before specimen collection.
JAMABacteriologic Diagnosis of Acute Pneumonia
114 Citations1976Michael Davidson
Bacteriologic analysis was performed on sputum, transtracheal aspirate (TA), and direct-needle aspirate of the lung (LA) obtained concurrently in each of 25 adult Navajo Indian patients with acute, community-acquired pneumonia, suggesting frequent tracheal contamination with potential pathogens and occasional multiple bacterial isolates from the LA of Patients with acute pneumonia.
Archives of Internal MedicineCapsular Types and Outcome of Bacteremic Pneumococcal Disease in the Antibiotic Era
109 Citations1974Maurice A. Mufson
For the control of pneumococcal disease, a polyvalent pneumitiscal polysaccharide vaccine would have broad application, especially among high-risk groups, and in patients with an extrapulmonary focus of infection or complicating chronic disease.
The Journal of Infectious DiseasesInteractions between Viruses and Bacteria in Patients with Chronic Bronchitis
108 Citations1976C. B. Smith, C. Golden +3 more
It is suggested that viral infections of the respiratory tract in patients with chronic obstructive pulmonary disease are associated with increased colonization by potentially pathogenic bacteria and may also predispose to infection with H. injluenxae.
Archives of Internal MedicineCommunity-Acquired Bacteremic Pneumococcal Pneumonia
103 Citations1984Anthony L. Esposito
The effects of advanced age on the manifestations and clinical course of community-acquired bacteremic pneumococcal pneumonia appear less pronounced than has been reported previously.
Scandinavian Journal of Infectious DiseasesDiagnosis of Pneumococcal Pneumonia: A Comparison between Microscopic Examination of Expectorate, Antigen Detection and Cultural Procedures
99 Citations1983Mats Kalin, Alf A. Lindberg
Gram stain and CIE on sputum were about equally effective and also strikingly complementary, alone diagnosing 42% and 48% of the patients, respectively, but together detecting 65% of them.
Annals of Internal MedicineUpdate: Pneumococcal Polysaccharide Vaccine Usage—United States
91 Citations1984
JAMAA Cost-Benefit Analysis of Immunization for Pneumococcal Pneumonia
71 Citations1981Kevin M. Patrick
It was found that when provider-centered and patient-centered costs and benefits were added, a program of immunizing those traditionally considered to be at high risk of contracting pneumococcal pneumonia was justified on a cost-benefit basis.
JAMAPneumococcal Vaccine in the United States
67 Citations1981Jan V. Hirschmann
There is currently no information to support widespread pneumococcal vaccination in this country, and further investigations are needed to determine in what situations this vaccine is worthwhile.
New England Journal of MedicineA Reassessment of Pneumococcal Vaccine
59 Citations1984Robert Austrian
Six years have elapsed since a polyvalent vaccine of pneumococcal capsular polysaccharides was licensed in the United States for the second time in three decades, and two earlier such vaccines had bee...
Archives of Internal MedicinePneumococcal Vaccine in the Hospital
47 Citations1983Robert S. Klein
A hospital-based program can increase pneumococcal immunization rates and would be directed at patients in whom serious pneumococCal disease is likely to develop.
Journal of the American Medical AssociationTHE RELIABILITY OF SPUTUM TYPING AND ITS RELATION TO SERUM THERAPY
47 Citations1935Jesse G. M. Bullowa
The serum treatment of pneumonia was first attempted more than forty years ago by Klemperer in Berlin and Elser in New York but could not be successfully introduced until different types of pneumococci were recognized and patients suffering from pneumonias due to specific types were treated with homologous serums.
PubMedComparison of community-acquired and nosocomial pneumococcal bacteremia.
44 Citations1981Joseph M. Mylotte, Thomas R. Beam
Patients with nosocomial disease had significantly more ultimately fatal disease and sustained more manipulation of the respiratory tract than patients with community-acquired bacteremia and could have received immunoprophylaxis.
The American Journal of MedicineEffect of underlying disease and age on pneumococcal serotype distribution
27 Citations1983Steven J. Weisholtz, Barry J. Hartman +1 more
The apparent predilection of nonvaccine serotypes to cause bacteremia in immunocompromised patients may be one factor limiting vaccine efficacy in this high-risk population.
The LancetPNEUMOCOCCAL TYPING AND THE PROBLEM OF ENDOGENOUS OR EXOGENOUS REINFECTION IN CHRONIC BRONCHITIS
26 Citations1971MargaretA. Calder, M. E. Schonell
It is suggested that in bronchitic patients it may sometimes be difficult to clear pneumococci completely from the respiratory tract.
CHEST JournalPneumococcal Vaccine In Elderly Patients With Copd
26 Citations1983Sheldon H. Landesman, Peter Smith +1 more
It is concluded that elderly persons with COPD have adequate antibody titers for at least one year after vaccination.
PubMedType-specific pneumococcal respiratory disease in the elderly and chronically III.
25 Citations1978W M Valenti, Maximilian Jenzer +1 more
Type-specific pneumococcal respiratory disease was studied in a chronic-disease hospital during a 27-month period and suggests that, theoretically, closed populations of elderly and chronically ill patients would benefit from vaccination in an attempt to control pneumitiscal pneumonia.
The Journal of Infectious DiseasesSerotypes of Streptococcus pneumoniae Isolated from Blood Cultures at Boston City Hospital Between 1979 and 1982
24 Citations1984M. A. Barry, D. E. Craven +1 more
It is demonstrated that most cases of pneumococcal bacteremia are caused by capsular types or groups present in the current vaccine and that minor changes in the types ofneumococci causing b acteremia have occurred during the past decade.
JAMAProspectus: The Prevention of Bacteremic Pneumococcal Pneumonia
19 Citations1974Allen B. Kaiser
Blood, cerebrospinal fluid, and respiratory isolates from 632 adults with pneumococcal pneumonia hospitalized from 1968 through 1972 were typed and the results were correlated with the 14 types currently being tested in pneumitiscal vaccines.
JAMAPneumococcal Vaccine: To Use or Not
19 Citations1981David W. Fraser
Formulating rational recommendations for using 14-valent pneumococcal vaccine in the United States has proved to be a formidable task.
Infection ControlHospital-Based Pneumococcal Immunization: The Epidemiologic Rationale and Its Implementation
18 Citations1982David S. Fedson
Military MedicineRapid Detection of Pneumococcal Antigens in Sputum and Blood Serum Using a Coagglutination Test
17 Citations1980Earl A. Edwards, Michael E. Kilpatrick +1 more
Infection and ImmunityHost Factors and Capsular Typing of Body Fluid Isolates in Fulminant Pneumococcal Infections
15 Citations1972Ronald M. Shapera, John M. Matsen
Pneumococci of the higher capsular types were prominent in children, and those of the lower types in adults, a finding in agreement with other recent studies.
Clinical Infectious DiseasesPneumococcal Antibodies in Patients with Chronic Obstructive Pulmonary Disease and Their Response to Pneumococcal Capsular Polysaccharides: Preliminary Results
14 Citations1981Anne L. Davis, Conrado P. Aranda +2 more
Journal of HygieneFrequencies of pneumococcal types causing serious infections in patients admitted to the Radcliffe Infirmary, Oxford, 1969–77
13 Citations1978D. C. Turk
Of the 124 pneumococcal strains isolated from body fluids of 124 patients at the Radcliffe Infirmary, Oxford 104 (84%), including 23 of those from patients who died, belonged to types included in the vaccines successfully used in South Africa and in Papua New Guinea.
The Pediatric Infectious Disease JournalEvaluation of a latex particle agglutination kit in pneumococcal disease
11 Citations1984Blaise L. Congeni, Howard J. Igel +1 more
Latex particle agglutination appears to be useful when cerebrospinal fluid is examined in patients with pneumococcal meningitis but does not appear to be sufficiently sensitive to warrant its use with serum or urine in Patients with invasive disease due to S. pneumoniae.
PubMedPneumococcal pneumonia: experience in a community hospital.
9 Citations1982Fredrica E. Smith, Jonathan M. Mann
Prospective studies in community hospitals should be considered to define more clearly the epidemiology of pneumococcal pneumonia in the nonurban United States population and contribute to a rational policy for use of pneumitiscal vaccine.
CHEST JournalEffects of 14-Valent Pneumococcal Capsular Polysaccharide Vaccine in Patients with COPD
8 Citations1984Anne L. Davis, C. Aranda +2 more